semaglutide e tirzepatide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Novo weight-loss drug may preserve

It all comes down to the form used, dosage, and individual health factors

For many, the experience is not just unpleasant

Medicare can cover it in limited situations tied to another accepted indication, but not as a broad obesity benefit for everyone right now

It belongs to a class of drugs known as GLP-1 and GIP receptor agonists , which help regulate blood sugar and appetite

doi: 10.1007/s001250051335 [DOI] [PubMed] [Google Scholar] 119.Reisi P, Alaei H, Babri S, Sharifi MR, Mohaddes G, Soleimannejad E

Direct-to-consumer drug sales are not likely to be the solution to high drug prices for most patients in the U.S., said Cubanski